the international immuno-oncology biomarker working group.Denkert, Carsten; Wienert, Stephan; Poterie, Audrey; Loibl, Sibylle; Budczies, Jan; Badve, Sunil; Bago-Horvath, Zsuzsanna; Bane, Anita; Bedri, Shahinaz; Brock, Jane; Chmielik, Ewa; Christgen, Matthias; Colpaert, Cecile; Demaria, Sandra; Van den Eynden, Gert; Floris, Giuseppe; Fox, Stephen B; Gao, Dongxia; Ingold Heppner, Barbara; Kim, S Rim;Kos, Zuzana; Kreipe, Hans H; Lakhani, Sunil R; Penault-Llorca, Frederique; Pruneri, Giancarlo; Radosevic-Robin, Nina;Rimm, David L; Schnitt, Stuart J; Sinn, Bruno V; Sinn, Peter; Sirtaine, Nicolas; O'Toole, Sandra A; Viale, Giuseppe; Van de Vijver, Koen; de Wind, Roland; von Minckwitz, Gunter; Klauschen, Frederick; Untch, Michael; Fasching, Peter A; Reimer, Toralf; Willard-Gallo, Karen; Michiels, Stefan; Loi, Sherene; Salgado, Roberto.Mod Pathol; 29(10): 1155-64, 2016 Oct.29.Downregulation of androgen receptor is strongly associated with diabetes in triple negative breast cancer patients.Collina, Francesca; Cerrone, Margherita; Peluso, Valentina; Laurentiis, Michelino De; Caputo, Roberta; Cecio, Rossella De; Liguori, Giuseppina; Botti, Gerardo; Cantile, Monica; Bonito, Maurizio Di.Am J Transl Res; 8(8): 3530-9, 2016.30.Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.Park, Chansub; Park, Kyeongmee; Kim, Jiyoung; Sin, Youngjoo; Park, Inseok; Cho, Hyunjin; Yang, Keunho; Bae, Byung Noe; Kim, Ki Whan; Ahn, Sookyung; Gwak, Geumhee.World J Surg Oncol; 14(1): 244, 2016.31.Prognostic and predictive value of Ki-67 in triple-negative breast cancer.Wang, Wei; Wu, Jiayi; Zhang, Peifeng; Fei, Xiaochun; Zong, Yu; Chen, Xiaosong; Huang, Ou; He, Jian-Rong; Chen, Weiguo; Li, Yafen; Shen, Kunwei; Zhu, Li.Oncotarget; 7(21): 31079-87, 2016 May 24.32.Genomic profiling of breast cancer in African-American women using MammaPrint.Nunes, Raquel A; Wray, Lynette; Mete, Mihriye; Herbolsheimer, Pia; Smith, Karen L; Bijelic, Lana; Boisvert, Marc E; Swain, Sandra M.Breast Cancer Res Treat; 159(3): 481-8, 2016 Oct.33.Ki-67 is a prognostic marker for hormone receptor positive tumors.Perez-Lopez, M E; Garcia-Gomez, J; Alves, M T; Paradela, A; Garcia-Mata, J; Garcia-Caballero, T.Clin Transl Oncol; 18(10): 996-1002, 2016 Oct.34.Quantitative proteomics revealed novel proteins associated with molecular subtypes of breast cancer.Suman, Shankar; Basak, Trayambak; Gupta, Prachi; Mishra, Sanjay; Kumar, Vijay; Sengupta, Shantanu; Shukla, Yogeshwer.J Proteomics; 148: 183-93, 2016 Oct 4.35.Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patients.Zhou, Meng; Zhong, Lei; Xu, Wanying; Sun, Yifan; Zhang, Zhaoyue; Zhao, Hengqiang; Yang, Lei; Sun, Jie.Sci Rep; 6: 31038, 2016.36.Comparison between Ki67 labeling index determined using image analysis software with virtual slide system and that determined visually in breast cancer.Maeda, Ichiro; Abe, Kayoko; Koizumi, Hirotaka; Nakajima, Chika; Tajima, Shinya; Aoki, Hiromi; Tsuchiya, Junichi;Tsuchiya, Seiko; Tsuchiya, Kyoko; Shimo, Arata; Tsugawa, Koichiro; Ueno, Takahiko; Tatsunami, Shinobu; Takagi, Masayuki.Breast Cancer; 23(5): 745-51, 2016 Sep.37.New insight on the biological role of p53 protein as a tumor suppressor: re-evaluation of its clinical significance in triple-negative breast cancer.Jin, Min-Sun; Park, In Ae; Kim, Ji Young; Chung, Yul Ri; Im, Seock-Ah; Lee, Kyung-Hun; Moon, Hyeong-Gon; Han, Wonshik; Noh, Dong-Young; Ryu, Han Suk.Tumour Biol; 37(8): 11017-24, 2016 Aug.38.Affluence and Breast Cancer.Lehrer, Steven; Green, Sheryl; Rosenzweig, Kenneth E.Breast J; 22(5): 564-7, 2016 Sep.39.Immunohistochemical expression of human epidermal growth factor receptor (HER)-4 and prognosis in patients with metastatic breast cancer.Deligonul, Adem; Evrensel, Turkkan; Avci, Nilufer; Ugras, Nesrin; Ture, Mehmet; Cubukcu, Erdem; Hartavi, Mustafa; Fatih Olmez, Omer;